{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:53:35Z","timestamp":1791824015316,"version":"4.3.4"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003896","name":"The Henry M Jackson Foundation for the Advancement of Military Medicine Inc","doi-asserted-by":"publisher","award":["HU0001-23-2-0125"],"award-info":[{"award-number":["HU0001-23-2-0125"]}],"id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cpsurg.2026.102133","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:03:13Z","timestamp":1784732593000},"page":"102133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["If it is in the adrenal gland, it is not essential (hypertension)"],"prefix":"10.1016","volume":"82","author":[{"given":"Clayton","family":"Kramm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8278-2023","authenticated-orcid":false,"given":"Warren","family":"Lockette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cpsurg.2026.102133_bib0001","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11906-014-0448-6","article-title":"Perioperative hypertensive emergencies","volume":"16","author":"Aronson","year":"2014","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40140-018-0248-7","article-title":"Preoperative hypertension","volume":"8","author":"Howell","year":"2018","journal-title":"Curr Anesthesiol Rep"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0003","first-page":"215","article-title":"Hypertension. Preoperative assessment and perioperative management","volume":"162","author":"Laslett","year":"1995","journal-title":"Western J Med"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0004","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/HYPERTENSIONAHA.118.11688","article-title":"Blood pressure targets in perioperative care: provisional considerations based on a comprehensive literature review","volume":"72","author":"Meng","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bja\/43.2.122","article-title":"Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients","volume":"43","author":"Prys-Roberts","year":"1971","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0006","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.jvca.2010.06.022","article-title":"Association of preanesthesia hypertension with adverse outcomes","volume":"24","author":"Wax","year":"2010","journal-title":"J Cardiothorac Vasc Anesthesia"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.kint.2022.12.021","article-title":"New advances in endocrine hypertension: from genes to biomarkers","volume":"103","author":"Fernandes-Rosa","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1163877","article-title":"Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism","volume":"14","author":"Karwacka","year":"2023","journal-title":"Front Endocr"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0009","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0889-8529(18)30103-8","article-title":"Hypertension in thyroid disorders","volume":"23","author":"Saito","year":"1994","journal-title":"Endocrinol Metabol Clin North Am"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022981801344","article-title":"Pheochromocytoma as an endocrine emergency","volume":"4","author":"Brouwers","year":"2003","journal-title":"Rev Endocr Metabol Disord"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0012","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2009-1051","article-title":"Risk factors for hemodynamic instability during surgery for pheochromocytoma","volume":"95","author":"Bruynzeel","year":"2010","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijsu.2014.04.001","article-title":"Current concepts of pheochromocytoma","volume":"12","author":"Conzo","year":"2014","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0014","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac004","article-title":"Perioperative management of pheochromocytomas and sympathetic paragangliomas","volume":"6","author":"Fagundes","year":"2022","journal-title":"J Endocr Soc"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jch.12084","article-title":"Pheochromocytoma\/paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma","volume":"15","author":"Fishbein","year":"2013","journal-title":"J Clin Hypertens"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000000784","article-title":"Acute hypertensive crisis secondary to pheochromocytoma during elective cosmetic surgery","volume":"135","author":"Frederick","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/j.2040-4603.2014.tb00559.x","article-title":"Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma","volume":"4","author":"Lenders","year":"2014","journal-title":"Compr Physiol"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0018","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9610(00)00296-8","article-title":"Adrenal pheochromocytoma remains a frequently overlooked diagnosis","volume":"179","author":"Lo","year":"2000","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0032-1331217","article-title":"Mortality associated with phaeochromocytoma","volume":"45","author":"Prejbisz","year":"2013","journal-title":"Hormone Metabol Res"},{"issue":"11","key":"10.1016\/j.cpsurg.2026.102133_bib0020","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of pheochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0021","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/EJE-15-0483","article-title":"Life-threatening events in patients with pheochromocytoma","volume":"173","author":"Riester","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0022","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0023","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0039-6060(96)80058-4","article-title":"Is laparoscopic adrenalectomy indicated for pheochromocytomas?","volume":"120","author":"Gagner","year":"1996","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/gs.2019.10.20","article-title":"Surgical approach to patients with pheochromocytoma","volume":"9","author":"Patel","year":"2020","journal-title":"Gland Surg"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.surg.2006.10.012","article-title":"Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?","volume":"141","author":"Toniato","year":"2007","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.cpsurg.2026.102133_bib0026","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/iju.15218","article-title":"Laparoscopic adrenalectomy for adrenal tumors with endocrine activity: perioperative management pathways for reduced complications and improved outcomes","volume":"30","author":"Utsumi","year":"2023","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0027","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.surg.2022.08.010","article-title":"Impact of dedicated multidisciplinary service on patient selection and outcomes for surgical treatment of primary aldosteronism","volume":"172","author":"Zhang","year":"2022","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0028","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ecl.2019.08.014","article-title":"Surgical approach to endocrine hypertension in patients with adrenal disorders","volume":"48","author":"Shank","year":"2019","journal-title":"Endocrinol Metabol Clin North Am"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0029","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocr Metab"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0030","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1053\/j.jvca.2017.02.023","article-title":"Perioperative management of pheochromocytoma","volume":"31","author":"Naranjo","year":"2017","journal-title":"J Cardiothorac Vasc Anesthesia"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0031","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000658-199011000-00003","article-title":"Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications?","volume":"212","author":"Charlson","year":"1990","journal-title":"Ann Surg"},{"issue":"35","key":"10.1016\/j.cpsurg.2026.102133_bib0032","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu285","article-title":"2014 ESC\/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0033","article-title":"The burden of perioperative hypertension\/hypotension: a systematic review","volume":"17","author":"Lizano-D\u00edez","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0034","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/ALN.0000000000000756","article-title":"Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery","volume":"123","author":"Monk","year":"2015","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/ALN.0000000000003610","article-title":"Perioperative blood pressure management","volume":"134","author":"Saugel","year":"2021","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0036","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5114\/ait.2022.123143","article-title":"Comparison of intraoperative arterial blood pressure lability during general anaesthesia in masked, uncontrolled hypertensive and adequately controlled hypertensive patients: a prospective observational study","volume":"54","author":"Siripruekpong","year":"2022","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0037","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/JS9.0000000000000390","article-title":"Preoperative \u03b1-blockade versus no blockade for pheochromocytoma\u2013paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis","volume":"109","author":"Wang","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0038","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/j.2040-4603.2019.tb00098.x","article-title":"Chromaffin cells of the adrenal medulla: physiology, pharmacology, and disease","volume":"9","author":"Carbone","year":"2019","journal-title":"Comp Physiol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0039","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","article-title":"The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease","volume":"35","author":"de Bresser","year":"2024","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0041","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","article-title":"International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents","volume":"20","author":"Casey","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0042","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.eprac.2022.09.003","article-title":"New biology of pheochromocytoma and paraganglioma","volume":"28","author":"Pacak","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0043","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0044","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0045","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0046","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/HYPERTENSIONAHA.122.19019","article-title":"Improved diagnostic accuracy of clonidine suppression testing using an age-related cutoff for plasma normetanephrine","volume":"79","author":"Remde","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/nutrit\/nuy036","article-title":"Food sources and biomolecular targets of tyramine","volume":"77","author":"Andersen","year":"2019","journal-title":"Nutr Rev"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0048","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2018.06.018","article-title":"Optimized reference intervals for plasma free metanephrines in patients with CKD","volume":"72","author":"Pamporaki","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0049","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma methoxy tyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocr"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0050","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0051","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"68Ga-DOTATATE and 18F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0052","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cancers16050986","article-title":"The additional value of somatostatin receptor positron emission computed tomography ([68Ga]Ga-DOTATOC PET\/CT) compared with magnetic resonance imaging of the head and neck region in paraganglioma patients: a pilot study","volume":"16","author":"de Bresser","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0053","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.suc.2024.02.014","article-title":"Management of pheochromocytomas and paragangliomas","volume":"104","author":"Passman","year":"2024","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0054","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Soltani","year":"2016","journal-title":"J Diabet Metabol Disord"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0056","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1353.005","article-title":"Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge","volume":"1073","author":"Cohen","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0057","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1196\/annals.1353.004","article-title":"1111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors","volume":"1073","author":"Kasperlik-Zaluska","year":"2006","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0058","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0059","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the italian society of endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1445-5994.2000.tb04358.x","article-title":"Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland","volume":"30","author":"McNeil","year":"2000","journal-title":"Australian New Zealand J Med"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0061","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0025-6196(26)01464-3","article-title":"Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series","volume":"56","author":"Sutton","year":"1981","journal-title":"Mayo Clinic Proc"},{"issue":"7","key":"10.1016\/j.cpsurg.2026.102133_bib0062","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s002689900454","article-title":"Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients","volume":"22","author":"Favia","year":"1998","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0063","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0064","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1988.tb15883.x","article-title":"Long-term results in 64 patients operated upon for pheochromocytoma","volume":"223","author":"Stenstr\u00f6m","year":"1988","journal-title":"Acta Med Scand"},{"issue":"7","key":"10.1016\/j.cpsurg.2026.102133_bib0065","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/bja\/56.7.781","article-title":"Anaesthetic management of patients with phaeochromocytoma","volume":"56","author":"Desmonts","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0066","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0067","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archinte.1969.00300120040006","article-title":"Commentary on incidence of primary aldosteronism: current estimations based on objective data","volume":"123","author":"Kaplan","year":"1969","journal-title":"Arch Int Med"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0068","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","article-title":"Reliability of screening methods for the diagnosis of primary aldosteronism","volume":"67","author":"Streeten","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0069","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an Aldosterone\/Renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0071","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0072","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0073","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","article-title":"Underdiagnosis of primary aldosteronism: a review of screening and detection","volume":"82","author":"Funes Hernandez","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0074","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: an update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/ijms25020900","article-title":"What we know about and what is new in primary aldosteronism","volume":"25","author":"Ekman","year":"2024","journal-title":"Int J Molec Sci"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0076","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diab Endocr"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0077","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0078","series-title":"Encyclopedia of Endocrine Diseases","first-page":"505","article-title":"Hypertension and the renin\u2013angiotensin\u2013aldosterone system","author":"Kaschina","year":"2018"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0079","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/a-0672-0836","article-title":"Aldosterone to renin ratio as screening tool in primary aldosteronism","volume":"127","author":"Schilbach","year":"2019","journal-title":"Exp Clin Endocr Diab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030142","article-title":"Adverse effects of aldosterone: beyond blood pressure","volume":"13","author":"Brown","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0081","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.vh.2018.10.004","article-title":"Chapter five: aldosterone and ion channels","volume":"109","author":"Valinsky","year":"2019","journal-title":"Vitamin Horm"},{"issue":"9","key":"10.1016\/j.cpsurg.2026.102133_bib0082","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metabol"},{"issue":"9","key":"10.1016\/j.cpsurg.2026.102133_bib0083","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","article-title":"Genetic causes of primary aldosteronism","volume":"51","author":"Seidel","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism","volume":"33","author":"Williams","year":"2022","journal-title":"Trends Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0086","first-page":"1029","article-title":"The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications","volume":"39","author":"Seccia","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0087","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","article-title":"Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension","volume":"85","author":"Stowasser","year":"2000","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0088","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005641","article-title":"Nonadherence to antihypertensive drugs: a systematic review and meta-analysis","volume":"96","author":"Abegaz","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0089","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Int Med"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0091","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0092","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s12020-024-03798-0","article-title":"Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests","volume":"85","author":"Ruiz-S\u00e1nchez","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0093","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1210\/clinem\/dgaa080","article-title":"Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism\u2014the EMIRA study","volume":"105","author":"Rossi","year":"2020","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0094","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4158\/EP-2020-0277","article-title":"Mineralocorticoid receptor antagonists decrease the rates of positive screening for primary aldosteronism","volume":"26","author":"Tezuka","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40292-020-00415-9","article-title":"Practice recommendations for diagnosis and treatment of the most common forms of secondary hypertension","volume":"27","author":"Rossi","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0096","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/clinem\/dgac654","article-title":"Exclusion tests in unilateral primary aldosteronism (ExcluPA) study","volume":"108","author":"Zhu","year":"2023","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0097","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0098","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jss.2020.05.099","article-title":"Evaluation of adrenal vein sampling use and outcomes in patients with primary aldosteronism","volume":"256","author":"Yeung","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0099","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of 11C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"11C-metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0102","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/EJE-22-0375","article-title":"Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis","volume":"187","author":"Chen","year":"2022","journal-title":"Eur J Endocr"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0103","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1097\/JS9.0000000000002048","article-title":"Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review","volume":"110","author":"Nayak","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0104","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1093\/ejendo\/lvad020","article-title":"Mineralocorticoid receptor antagonists for primary aldosteronism-appropriate or not?","volume":"188","author":"Ragnarsson","year":"2023","journal-title":"Eur J Endocr"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diab Endocr"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0107","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3171\/jns.1964.21.4.0318","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"21","author":"Cushing","year":"1964","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0108","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"10418","key":"10.1016\/j.cpsurg.2026.102133_bib0109","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet (Brit Ed)"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0110","first-page":"4","article-title":"Cushing syndrome","volume":"11","author":"Nieman","year":"2025","journal-title":"Nat Rev"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0111","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40618-022-01754-1","article-title":"Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies","volume":"45","author":"Giuffrida","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0112","article-title":"Epidemiology and mortality of Cushing\u2019s syndrome. Bailli\u00e8re's Best practice & research","volume":"35","author":"Hakami","year":"2021","journal-title":"Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.cpsurg.2026.102133_bib0114","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing's syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0115","article-title":"Cushing's syndrome: overview of clinical presentation, diagnostic tools and complications. Bailli\u00e8re's Best practice & research","volume":"34","author":"Barbot","year":"2020","journal-title":"Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.HYP.12.1.11","article-title":"Altered circadian blood pressure rhythm in patients with Cushing's syndrome","volume":"12","author":"Imai","year":"1988","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.cpsurg.2026.102133_bib0117","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0118","first-page":"467","article-title":"Hypertension in Cushing's syndrome. Bailli\u00e8re's best practice & research","volume":"20","author":"Magiakou","year":"2006","journal-title":"Clin Endocrinol Metabol"},{"issue":"7","key":"10.1016\/j.cpsurg.2026.102133_bib0119","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.cpsurg.2026.102133_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13113","article-title":"Long-term morbidity and mortality in patients with Cushing's syndrome","volume":"34","author":"Braun","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0121","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11102-022-01258-4","article-title":"Cardiovascular health and mortality in Cushing\u2019s disease","volume":"25","author":"Coulden","year":"2022","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0122","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0123","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0124","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2019.00321","article-title":"The pathophysiology and treatment of hypertension in patients with Cushing's syndrome","volume":"10","author":"Barbot","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.cpsurg.2026.102133_bib0126","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"7","key":"10.1016\/j.cpsurg.2026.102133_bib0127","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0128","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0129","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac010","article-title":"Perioperative management of a patient with Cushing disease","volume":"6","author":"Varlamov","year":"2022","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0130","article-title":"Cushing syndrome: old and new genes. Bailli\u00e8re's Best practice & research","volume":"34","author":"Tatsi","year":"2020","journal-title":"Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ecl.2018.02.007","article-title":"Genetics of Cushing\u2019s syndrome","volume":"47","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2018","journal-title":"Endocrinol Metabol Clin North Am"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0132","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"issue":"12","key":"10.1016\/j.cpsurg.2026.102133_bib0133","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0134","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14008","article-title":"The clinical impact of [68 Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone - secreting tumors","volume":"91","author":"Wannachalee","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-019-00972-w","article-title":"Diagnostic utility of gallium-68-somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience","volume":"22","author":"Varlamov","year":"2019","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.cpsurg.2026.102133_bib0136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11102-022-01218-y","article-title":"Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome","volume":"25","author":"He","year":"2022","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.cpsurg.2026.102133_bib0137","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.cpsurg.2026.102133_bib0138","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cpsurg.2026.102133_bib0139","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.cpsurg.2026.102133_bib0140","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0141","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12020-020-02297-2","article-title":"Cardiovascular and metabolic risk factors in patients with subclinical Cushing","volume":"70","author":"Petramala","year":"2020","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.cpsurg.2026.102133_bib0142","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of Endocrine Disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0143","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0144","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.cpsurg.2026.102133_bib0145","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/diagnostics12112772","article-title":"The entity of Connshing syndrome: primary aldosteronism with autonomous cortisol secretion","volume":"12","author":"Carsote","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cpsurg.2026.102133_bib0146","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.632543","article-title":"Molecular genetic and genomic alterations in Cushing\u2019s syndrome and primary aldosteronism","volume":"12","author":"Kamilaris","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6186","key":"10.1016\/j.cpsurg.2026.102133_bib0147","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.1254901","article-title":"A unified cause for adrenal Cushing's syndrome","volume":"344","author":"Kirschner","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1507\/endocrj.EJ25-0312","article-title":"False-positive results of adrenal venous sampling due to mild autonomous cortisol secretion in a patient with primary aldosteronism: a case report with review of literature","volume":"73","author":"Wada","year":"2026","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.cpsurg.2026.102133_bib0149","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.27.1.144","article-title":"Hypertensive urgencies and emergencies: prevalence and clinical presentation","volume":"27","author":"Zampaglione","year":"1996","journal-title":"Hypertension"}],"container-title":["Current Problems in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011384026001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011384026001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:32:07Z","timestamp":1791822727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011384026001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":149,"alternative-id":["S0011384026001589"],"URL":"https:\/\/doi.org\/10.1016\/j.cpsurg.2026.102133","relation":{},"ISSN":["0011-3840"],"issn-type":[{"value":"0011-3840","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"If it is in the adrenal gland, it is not essential (hypertension)","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpsurg.2026.102133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102133"}}